The nation's largest technology companies are no longer content to plug into the grid. They are buying its steady heartbeat, and sucking the lifeblood out of the Earth. Within six days, Amazon and Google locked in 20-year claims on nuclear output from Maryland to 11 reactors across the country, all while promising fresh megawatts and a shield for ordinary households. Yet a closer look at who borrows, who benefits, and who waits suggests that the so-called nuclear renaissance may be less a gift to the public than a private reservation - a draining of the most dependable electricity America has.

Key points:

• Amazon and Constellation announced a 20-year deal on Sept. 30 covering 690 megawatts at Calvert Cliffs in Maryland.
• Google and Constellation followed Oct. 6 with a $4.3 billion expansion across 11 reactors.
• The Ratepayer Protection Pledge promises data centers will not raise household bills.
• Critics say nuclear has not yet met real data center demand and new reactors remain a decade away.
• The Energy Department approved roughly $4.4 billion in loans to restart three nuclear facilities.

The mechanics of the deals fit on a napkin, though the implications do not. On Sept. 30,

Shares of Trump Media & Technology Group, the parent company of Truth Social, fell more than 7.5% on Monday, Oct. 20, to close at an all-time low of $6.40, according to market data reported by The Daily Beast [10]. The decline extended a broader slump that has pushed the stock down 29% over the past month, the data showed [10].

The sell-off came as third-party analytics data indicated that daily traffic on the platform had fallen by more than 30% over the past year [10].

The company, which operates the social network launched by President Donald Trump, has reported quarterly losses and pursued a series of strategic pivots in recent quarters, according to company filings and news reports [10].

Stock Performance and Market Reaction

The stock's close at $6.40 on Oct. 20 marked a new record low for Trump Media, according to exchange data cited by multiple outlets [10]. The previous record low came in June, when shares hit $7.61, according to The Daily Beast.

Before Monday's session, the company had already hit all-time low stock prices on multiple occasions over the past year, market data showed.

The decline accelerated over the past month, with the stock falling 29%

• Nattokinase, a fermented soybean enzyme, has demonstrated ability to degrade SARS-CoV-2 spike protein in two independent laboratory studies.
• The enzyme works through multiple mechanisms: direct fibrinolysis, activation of the body's own clot-dissolving system, and inactivation of PAI-1.
• No controlled human trial has yet proven nattokinase clears vaccine-derived spike from human tissue.
• Dosing matters significantly: 10,800 FU/day showed plaque reduction in one study while 2,000 FU/day showed no effect in a randomized trial.
• Safety precautions are essential as nattokinase is a potent fibrinolytic that can increase bleeding risk with anticoagulants.

A centuries-old fermented food meets modern molecular biology

In September 2022, researchers at Josiah University in Sama, Japan, published findings in the journal Molecules that a fermented soybean enzyme called nattokinase could degrade the SARS-CoV-2 spike protein in laboratory conditions. This discovery connected a staple of traditional Japanese cuisine to one of the most pressing biological questions of the pandemic era: what happens when spike protein persists in the body, and can anything safely remove it?

The answer to that question remains incomplete, but the evidence is compelling enough that millions of people have already begun using nattokinase on their own — often without waiting for